Tvardi Therapeutics
Price & Volume
Stats
See more52W Range | $1.50-$43.65 |
Market Cap | $19.7M |
Shares Short | 542,999 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.27 |
News
See moreYahoo Finance • 25 days ago
Tvardi's TTI-109 Shows Improved Tolerability And Target Engagement In Phase 1 Study
Yahoo Finance • 2 months ago
Russell 3000 Shuffle: Ocugen, Nektar slated to join among healthcare stocks; Nano-X to drop off
Yahoo Finance • 7 months ago
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Yahoo Finance • 8 months ago
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
About
CEO | Dr. Imran Alibhai Ph.D. |
CFO | Mr. Dan Conn J.D., M.B.A. |
Address | 3 Sugar Creek Center Boulevard, Sugar Land, TX, United States, 77478 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |